141 related articles for article (PubMed ID: 19220278)
41. Risk factors for unlicensed and off-label drug use in children outside the hospital.
Schirm E; Tobi H; de Jong-van den Berg LT
Pediatrics; 2003 Feb; 111(2):291-5. PubMed ID: 12563053
[TBL] [Abstract][Full Text] [Related]
42. Paediatric drug prescribing. A comparison of Tenerife (Canary Islands, Spain) and Sweden.
Sanz EJ; Bergman U; Dahlström M
Eur J Clin Pharmacol; 1989; 37(1):65-8. PubMed ID: 2591465
[TBL] [Abstract][Full Text] [Related]
43. A population-based study of prescribing trends in a potentially vulnerable paediatric population from 1999 to 2012.
Sears K; Elms S; Whitehead M; Tranmer JE; Edge DS; VanDenKerkhof EG
Int J Pharm Pract; 2019 Dec; 27(6):545-554. PubMed ID: 31373071
[TBL] [Abstract][Full Text] [Related]
44. Association of Industry Payments to Physicians With the Prescribing of Brand-name Statins in Massachusetts.
Yeh JS; Franklin JM; Avorn J; Landon J; Kesselheim AS
JAMA Intern Med; 2016 Jun; 176(6):763-8. PubMed ID: 27159336
[TBL] [Abstract][Full Text] [Related]
45. Evaluation of electronic databases used to identify solid oral dosage forms.
Raschke CG; Hatton RC; Weaver SJ; Belgado BS
Am J Health Syst Pharm; 2003 Sep; 60(17):1735-40. PubMed ID: 14503109
[TBL] [Abstract][Full Text] [Related]
46. The Pharmaceutical Benefits Scheme and implications for paediatric prescribing.
Sinha Y; Brien JA; Craig JC
J Paediatr Child Health; 2009 Jun; 45(6):351-7. PubMed ID: 19490409
[TBL] [Abstract][Full Text] [Related]
47. Changes in anticonvulsant prescribing for Australian children: implications for Quality Use of Medicines.
Cohen SA; Lawson JA; Graudins LV; Pearson SA; Gazarian M
J Paediatr Child Health; 2012 Jun; 48(6):490-5. PubMed ID: 22050665
[TBL] [Abstract][Full Text] [Related]
48. Off-label and unlicensed utilisation of medicines in a French paediatric hospital.
Joret-Descout P; Prot-Labarthe S; Brion F; Bataille J; Hartmann JF; Bourdon O
Int J Clin Pharm; 2015 Dec; 37(6):1222-7. PubMed ID: 26394784
[TBL] [Abstract][Full Text] [Related]
49. A survey of the use of off-label and unlicensed drugs in a Dutch children's hospital.
't Jong GW; Vulto AG; de Hoog M; Schimmel KJ; Tibboel D; van den Anker JN
Pediatrics; 2001 Nov; 108(5):1089-93. PubMed ID: 11694685
[TBL] [Abstract][Full Text] [Related]
50. Eunice Kennedy Shriver National Institute of Child Health and Human Development Pediatrics Formulation Initiative: proceedings from the Second Workshop on Pediatric Formulations.
Giacoia GP; Taylor-Zapata P; Zajicek A
Clin Ther; 2012 Nov; 34(11):S1-10. PubMed ID: 23149008
[TBL] [Abstract][Full Text] [Related]
51. Paediatric off-label and unlicensed prescribing in primary care in Malta: Prospective observational drug utilisation study.
Ellul IC; Grech V; Attard-Montalto S
Int J Risk Saf Med; 2015; 27(3):123-34. PubMed ID: 26410246
[TBL] [Abstract][Full Text] [Related]
52. Pediatric Off-Label and Unlicensed Drug Use and Its Implications.
Gore R; Chugh PK; Tripathi CD; Lhamo Y; Gautam S
Curr Clin Pharmacol; 2017; 12(1):18-25. PubMed ID: 28322168
[TBL] [Abstract][Full Text] [Related]
53. Unlicensed and off-label prescription of respiratory drugs to children.
't Jong GW; Eland IA; Sturkenboom MC; van den Anker JN; Strickerf BH
Eur Respir J; 2004 Feb; 23(2):310-3. PubMed ID: 14979509
[TBL] [Abstract][Full Text] [Related]
54. Lack of appropriate formulations of medicines for children in the community.
Schirm E; Tobi H; de Vries TW; Choonara I; De Jong-van den Berg LT
Acta Paediatr; 2003 Dec; 92(12):1486-9. PubMed ID: 14971804
[TBL] [Abstract][Full Text] [Related]
55. The EU's new paediatric medicines legislation: serving children's needs?
Permanand G; Mossialos E; McKee M
Arch Dis Child; 2007 Sep; 92(9):808-11. PubMed ID: 17715445
[TBL] [Abstract][Full Text] [Related]
56. [Off-label use of psychotropic medications in pediatric wards: a prospective study].
Winterfeld U; Le Heuzey MF; Acquaviva E; Mouren MC; Brion F; Bourdon O
Arch Pediatr; 2009 Sep; 16(9):1252-60. PubMed ID: 19640689
[TBL] [Abstract][Full Text] [Related]
57. The European paediatric initiative: 1 year of experience.
Saint-Raymond A; Seigneuret N
Paediatr Drugs; 2009; 11(1):9-10. PubMed ID: 19127942
[TBL] [Abstract][Full Text] [Related]
58. The extent of unlicensed and off-label drug use in the paediatric ward of a district general hospital in Northern Ireland.
Craig JS; Henderson CR; Magee FA
Ir Med J; 2001 Sep; 94(8):237-40. PubMed ID: 11758625
[TBL] [Abstract][Full Text] [Related]
59. Use of unlicensed and off-label medications in paediatric gastroenterology with a review of the commonly used formularies in the UK.
Dick A; Keady S; Mohamed F; Brayley S; Thomson M; Lloyd BW; Heuschkel R; Afzal NA
Aliment Pharmacol Ther; 2003 Feb; 17(4):571-5. PubMed ID: 12622766
[TBL] [Abstract][Full Text] [Related]
60. Incorrect or unsubstantiated indications listed for selected antimicrobials in the Physicians' Desk Reference.
Rybak MJ; Gleckman R
Am J Hosp Pharm; 1979 Jun; 36(6):738. PubMed ID: 463882
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
